Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05RMW
|
|||
| Former ID |
DCL001042
|
|||
| Drug Name |
ZD-3638
|
|||
| Synonyms |
ZD-3638; SCHEMBL1152094; CHEMBL264026
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Schizophrenia [ICD-11: 6A20] | Terminated | [1] | |
| Company |
AstraZeneca
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C28H30N2O2S
|
|||
| Canonical SMILES |
CCS(=O)C1=C(C=CC=N1)C2(CCN(CC2)CC34CC(C5=CC=CC=C53)C6=CC=CC=C46)O
|
|||
| InChI |
1S/C28H30N2O2S/c1-2-33(32)26-25(12-7-15-29-26)28(31)13-16-30(17-14-28)19-27-18-22(20-8-3-5-10-23(20)27)21-9-4-6-11-24(21)27/h3-12,15,22,31H,2,13-14,16-19H2,1H3
|
|||
| InChIKey |
LVMVFEHQMHETDS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| SuperDrug ATC ID |
J01FA10
|
|||
| SuperDrug CAS ID |
cas=083905015
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.